Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease

Internal and Emergency Medicine

Volumn 11, Issue 4, 2016, Pages 519-527

  Marcun, Robert ^a   Stankovic, Ivan ^b   Vidakovic, Radosav ^b   Farkas, Jerneja ^c   Kadivec, Sasa ^a   Putnikovic, Biljana ^b   Ilic, Ivan ^b   Neskovic, Aleksandar N ^b   Lainscak, Mitja ^c,d  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d General Hospital Celje   (Slovenia)

Author keywords

Chronic obstructive pulmonary disease; Heart failure with preserved ejection fraction; Outcome; Prevalence

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; BLOOD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; MALE; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

AGED; BIOMARKERS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE;

EID: 84944691396     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1319-0     Document Type: Article

References (38)

1. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155(3):179–191
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J (2007) Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555
3. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC, Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847
4. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11(2):130–139
5. Packer M (2011) Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease. Circ Heart Fail 4(5):538–540
6. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539–2550
7. Chan MM, Lam CS (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15(6):604–613
8. Bozkanat E, Tozkoparan E, Baysan O, Deniz O, Ciftci F, Yokusoglu M (2005) The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J Int Med Res 33:537–544
9. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr (2004) Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109:3176–3181
10. Kwon BJ, Kim DB, Jang SW, Yoo KD, Moon KW, Shim BJ, Ahn SH, Cho EJ, Rho TH, Kim JH (2010) Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 12(12):1339–1344
11. Lainscak M, Kadivec S, Kosnik M, Benedik B, Bratkovic M, Jakhel T, Marcun R, Miklosa P, Stalc B, Farkas J (2013) Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. J Am Med Dir Assoc 14(6):450.e1–e6
12. Farkas J, Kadivec S, Kosnik M, Lainscak M (2011) Effectiveness of discharge-coordinator intervention in patients with chronic obstructive pulmonary disease: study protocol of a randomized controlled clinical trial. Respir Med 105(Suppl 1):S26–S30
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shamewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57(6):450–458
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133
16. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713
17. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165–1185
18. Berry CE, Wise RA (2010) Mortality in COPD: causes, risk factors, and prevention. COPD 7:375–382
19. Ekstrom MP, Wagner P, Strom KE (2011) Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183:1032–1036
20. Sin DD, Man SF (2008) Impact of cancers and cardiovascular disease in chronic obstructive pulmonary disease. Obstructive, occupational and environmental diseases. Curr Opin Pulm Med 14(2):115–121
21. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, Radaeli A, Clini E (2011) Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 25(3):443–451
22. Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW (2005) Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331:1379–1386
23. Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 11:1182–1188
24. Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Hamda KB, Amor AB, Najjar MF, Knani J (2006) Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 174(9):990–996
25. Abusaid GH, Barbagelata A, Tuero E, Mahmood A, Sharma G (2009) Diastolic dysfunction and COPD exacerbation. Postgrad Med 121(4):76–81
26. Freixa X, Portillo K, Paré C, Garcia-Aymerich J, Gomez FP, Benet M, Roca J, Farrero E, Ferrer J, Fernandez-Palomeque C, Antó JM, Barberà JA (2013) Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J 41(4):784–791
27. Nishimura K, Nishimura T, Onishi K, Oga T, Hasegawa Y, Jones PW (2014) Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 9:155–162
28. Huang YS, Feng YC, Zhang J, Bai L, Huang W, Li M, Sun Y (2014) Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clin Interv Aging 10:81–87
29. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEniery CM, Donaldson K, Newby DE, Macnee W (2008) Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 63(4):306–311
30. Chhabra SK, Gupta M (2010) Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas. Indian J Chest Dis Allied Sci 52:225–238
31. Bhalla V, Willis S, Maisel AS (2004) B-type natriuretic peptide: the level and the drug–partners in the diagnosis of congestive heart failure. Congest Heart Fail 10(1 Suppl 1):3–27
32. Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP (2005) The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26:2277–2284
33. Abroug F, Ouanes-Besbes L(2008) Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Curr Opin Crit Care 14(3): 340–347
34. Wang QP, Cao XZ, Wang XD, Gu J, Wen LM, Mao LM, Shan PN, Tang AG (2013) Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis. PLOS One 8(1) (Article ID e52553)
35. Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, Hancox RJ (2011) Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 66(9):764–768
36. Marcun R, Sustic A, Brguljan PM, Kadivec S, Farkas J, Kosnik M, Coats AJ, Anker SD, Lainscak M (2012) Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol 161(3):156–159
37. Krüger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, Janssens U (2004) Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 147(1):60–65
38. Henzler T, Roeger S, Meyer M, Schoepf UJ, Nance JW Jr, Haghi D, Kaminski WE, Neumaier M, Schoenberg SO, Fink C (2012) Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur Respir J 39(4):919–926